A MOLECULAR APPROACH TO GONADOTROPIN RECEPTOR REGULATION

促性腺激素受体调节的分子方法

基本信息

项目摘要

We have successfully developed procedures to solubilize LH/hCG receptors (LHR) from porcine and rat ovaries in high yield. Porcine and rat LHR have been purified to apparent homogeneity by a two-step hCG-Sepharose affinity chromatographic procedure. The predominant subunit of LHR so purified has a molecular weight of 70,000 - 80,000 Daltons under denaturing reducing conditions. During the proposed grant period, the physico-chemical and biological properties of purified rat and porcine LHR will be compared. Antibodies to porcine LHR will be developed in rabbits, and rat LHR will be injected into mice with the goal of producing a monoclonal antibody to rat LHR. Antibodies will be characterized by immunochemical techniques and their biological properties will be tested using isolated receptors, membranes, cultured cells and the whole animal. The molecular basis of receptor regulation by hormones will be analyzed through direct measurements of rates of synthesis and degradation of LHR by specific immunoprecipitation methodology. Receptor antibodies will provide a superb analytical tool for investigation of the molecular biology of LHR synthesis, processing and turnover. LHR antibodies will not only be critical tools for investigation of ovarian physiology at the molecular level, but also may have significant practical application in immunocontraception and in understanding infertility of ovarian origin and in the development of monoclonal LHR antibody-drug conjugates which may be useful in therapy of ovarian cancer.
我们已经成功地开发了溶解LH/hCG受体的程序

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAY wimalasena WIMALASENA其他文献

JAY wimalasena WIMALASENA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAY wimalasena WIMALASENA', 18)}}的其他基金

APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
细胞凋亡
  • 批准号:
    6342200
  • 财政年份:
    2000
  • 资助金额:
    $ 9.9万
  • 项目类别:
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
细胞凋亡
  • 批准号:
    6032882
  • 财政年份:
    2000
  • 资助金额:
    $ 9.9万
  • 项目类别:
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
细胞凋亡
  • 批准号:
    6489338
  • 财政年份:
    2000
  • 资助金额:
    $ 9.9万
  • 项目类别:
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
细胞凋亡
  • 批准号:
    6626727
  • 财政年份:
    2000
  • 资助金额:
    $ 9.9万
  • 项目类别:
REGULATION OF BREAST CANCER CELL CYCLE BY ESTRADIOL
雌二醇对乳腺癌细胞周期的调节
  • 批准号:
    2429869
  • 财政年份:
    1996
  • 资助金额:
    $ 9.9万
  • 项目类别:
REGULATION OF BREAST CANCER CELL CYCLE BY ESTRADIOL
雌二醇对乳腺癌细胞周期的调节
  • 批准号:
    2112531
  • 财政年份:
    1996
  • 资助金额:
    $ 9.9万
  • 项目类别:
REGULATION OF BREAST CANCER CELL CYCLE BY ESTRADIOL
雌二醇对乳腺癌细胞周期的调节
  • 批准号:
    2712747
  • 财政年份:
    1996
  • 资助金额:
    $ 9.9万
  • 项目类别:
EFFECTS OF ALCOHOL ON HUMAN OVARIAN CELL FUNCTION
酒精对人类卵巢细胞功能的影响
  • 批准号:
    3112386
  • 财政年份:
    1992
  • 资助金额:
    $ 9.9万
  • 项目类别:
EFFECTS OF ALCOHOL ON HUMAN OVARIAN CELL FUNCTION
酒精对人类卵巢细胞功能的影响
  • 批准号:
    2044423
  • 财政年份:
    1992
  • 资助金额:
    $ 9.9万
  • 项目类别:
ALCOHOL EFFECTS ON OVARIAN CELL FUNCTION
酒精对卵巢细胞功能的影响
  • 批准号:
    2044425
  • 财政年份:
    1992
  • 资助金额:
    $ 9.9万
  • 项目类别:

相似海外基金

Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9981001
  • 财政年份:
    2017
  • 资助金额:
    $ 9.9万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9751102
  • 财政年份:
    2017
  • 资助金额:
    $ 9.9万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9397073
  • 财政年份:
    2017
  • 资助金额:
    $ 9.9万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    10223410
  • 财政年份:
    2017
  • 资助金额:
    $ 9.9万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
  • 批准号:
    7951676
  • 财政年份:
    2008
  • 资助金额:
    $ 9.9万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
  • 批准号:
    7606036
  • 财政年份:
    2006
  • 资助金额:
    $ 9.9万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7375053
  • 财政年份:
    2005
  • 资助金额:
    $ 9.9万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7201220
  • 财政年份:
    2004
  • 资助金额:
    $ 9.9万
  • 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    6980810
  • 财政年份:
    2003
  • 资助金额:
    $ 9.9万
  • 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
  • 批准号:
    6419444
  • 财政年份:
    2000
  • 资助金额:
    $ 9.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了